...
首页> 外文期刊>Journal of Clinical Microbiology >Comparison of Saramis 4.12 and IVD 3.0 Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Identification of Mycobacteria from Solid and Liquid Culture Media
【24h】

Comparison of Saramis 4.12 and IVD 3.0 Vitek MS Matrix-Assisted Laser Desorption Ionization–Time of Flight Mass Spectrometry for Identification of Mycobacteria from Solid and Liquid Culture Media

机译:比较Saramis 4.12和IVD 3.0 Vitek MS基质辅助激光解吸电离-飞行时间质谱法从固体和液体培养基中鉴定分枝杆菌的比较

获取原文
           

摘要

The genus Mycobacterium consists of 177 species whose taxonomy has constantly been evolving over the past few decades. The major causes of morbidity and mortality are due to mycobacteria belonging to the Mycobacterium tuberculosis complex (MTC), with 9.6 million people newly infected and 1.5 million people dying from tuberculosis every year (1). Nontuberculous mycobacteria (NTM) comprise a large group of organisms widely present in the environment and considered opportunistic pathogens causing pulmonary, soft tissue, lymphatic, and disseminated infections (2). Species such as M. abcsessus, M. xenopi, and M. chimaera have also been involved in nosocomial outbreaks (3–6). An accurate identification (ID) of NTM is, then, important for epidemiological and public health and for therapeutic reasons. Species identification is especially essential in diagnosis of M. avium complex (MAC) lung disease to differentiate transient colonization by different species from chronic pulmonary infection (2). Identification of mycobacterial isolates has traditionally been based on phenotypic characteristics and conventional biochemical tests, which were complex and required long incubation times. More recently, molecular methods such as DNA sequencing and DNA hybridization have become the new “gold standards” for mycobacterial identification. Although these techniques are fast and specific ways of identifying main Mycobacterium spp., they remain expensive, are available for only a limited number of common species, and require a high level of technical expertise. The limitations encountered with currently available methods led several investigators to suggest the use of matrix-assisted laser desorption ionization–time of flight mass spectrometry (MALDI-TOF MS) as an alternative strategy. MALDI-TOF MS is now predominant in an increasing number of clinical laboratories (7). This technique is quite simple and cost-effective (8) and allows rapid identification of organisms on the basis of spectral fingerprints produced by extracted proteins. It was initially evaluated with mycobacterial intact cells (9–12), but several investigators worked on improving inactivation and protein extraction (13–20). Most published studies assessed the performance of MALDI-TOF BioTyper (Bruker Daltonics, Bremen, Germany) (15, 17, 19–31). Few of them evaluated Vitek MS (bioMérieux, Marcy l'Etoile, France) (16, 17, 20, 24, 25, 32). Performances ranged widely, from 0% (24) to 94.4% (17) correct identifications depending on database versions, algorithms, and media (liquid or solid) used. We aimed to assess identification of Mycobacterium spp. from both liquid and solid media through two distinct databases: the Saramis v4.12 Vitek MS-Plus RUO (research use only) open database and the v3.0 CE-marked In Vitro Diagnostic (IVD). To our knowledge, IVD v3.0 has been evaluated only for mycobacteria growing from solid media (20). We aimed to establish the performance of this technique in the routine clinical microbiology laboratory and to highlight its limits.
机译:分枝杆菌属由177个物种组成,其分类学在过去几十年中一直在发展。发病率和死亡率的主要原因是属于结核分枝杆菌复合体(MTC)的分枝杆菌,每年有960万人新感染,而150万人死于结核病(1)。非结核分枝杆菌(NTM)包括一大批广泛存在于环境中的生物,被认为是引起肺,软组织,淋巴和弥散性感染的机会病原体(2)。诸如阿布斯杆菌(M. abcsessus),异种沙门氏菌(M. xenopi)和奇马分支杆菌(M. chimaera)等物种也参与了医院内暴发(3–6)。因此,NTM的准确识别(ID)对于流行病学和公共卫生以及治疗原因很重要。物种鉴定对于诊断鸟分枝杆菌(MAC)肺部疾病尤其重要,可以区分不同物种的短暂定植与慢性肺部感染(2)。分枝杆菌分离株的鉴定传统上是基于表型特征和常规生化试验,这是复杂的,需要较长的孵育时间。最近,诸如DNA测序和DNA杂交等分子方法已成为分枝杆菌鉴定的新“金标准”。尽管这些技术是识别主要分枝杆菌属物种的快速且特定的方法,但它们仍然昂贵,仅可用于有限数量的常见物种,并且需要高水平的技术专长。当前可用方法的局限性导致一些研究者建议使用基质辅助激光解吸电离-飞行时间质谱(MALDI-TOF MS)作为替代策略。如今,MALDI-TOF MS在越来越多的临床实验室中占主导地位(7)。该技术非常简单且具有成本效益(8),并且可以根据提取的蛋白质产生的光谱指纹快速鉴定生物。最初使用分枝杆菌完整细胞对其进行了评估(9-12),但一些研究人员致力于改善失活和蛋白质提取(13-20)。大多数发表的研究评估了MALDI-TOF BioTyper(德国不来梅的布鲁克·道尔顿公司)的性能(15、17、19–31)。他们中很少有人评估Vitek MS(法国,马赛·埃托伊尔的bioMérieux)(16、17、20、24、25、32)。根据数据库版本,算法和所使用的介质(液体或固体),性能的范围很广,从0%(24)到94.4%(17)正确标识。我们旨在评估分枝杆菌属的鉴定。通过两个不同的数据库从液体和固体介质中提取:Saramis v4.12 Vitek MS-Plus RUO(仅用于研究)开放数据库和带有v3.0 CE标记的体外诊断(IVD)。据我们所知,IVD v3.0仅针对从固体培养基中生长出来的分枝杆菌进行了评估(20)。我们旨在在常规临床微生物学实验室中建立这项技术的性能,并强调其局限性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号